The rise of biologics, biosimilars, and advanced therapies is reshaping the specialty drug distribution market. These products often require cold chain logistics—temperature‑controlled transport and storage—to preserve potency and safety. Specialty distributors and pharmacies must invest in cold‑chain infrastructure, real‑time monitoring, and contingency planning, which increases...